skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 16.11d (Release date: 2016-11-28)
SearchBox Top
SearchBox Bottom
Sargramostim Plasmid DNA Hepatocellular Carcinoma Vaccine Adjuvant (Code C48420)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Sargramostim Plasmid DNA Hepatocellular Carcinoma Vaccine Adjuvant

Definition: A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (granulocyte-macrophage colony-stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered hepatocellular carcinoma vaccine. (NCI05)

Label: Sargramostim Plasmid DNA Hepatocellular Carcinoma Vaccine Adjuvant

NCI Thesaurus Code: C48420 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1541364  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
GM-CSF Plasmid DNA Hepatocellular Carcinoma Vaccine
Sargramostim Plasmid DNA Hepatocellular Carcinoma Vaccine Adjuvant

External Source Codes: 
PDQ Closed Trial Search ID 390313
PDQ Open Trial Search ID 390313 (check for NCI PDQ open clinical trial info)
UMLS CUI C1541364

Other Properties:
Name Value (qualifiers indented underneath)
code C48420
Legacy_Concept_Name Sargramostim_Plasmid_DNA_Hepatocellular_Carcinoma_Vaccine_Adjuvant
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48420

Mainbox Bottom